These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16829612)

  • 1. Rapid genetic grouping of factor h-binding protein (genome-derived neisserial antigen 1870), a promising group B meningococcal vaccine candidate.
    Beernink PT; Leipus A; Granoff DM
    Clin Vaccine Immunol; 2006 Jul; 13(7):758-63. PubMed ID: 16829612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C Vaccine.
    Rossi R; Beernink PT; Giuntini S; Granoff DM
    Clin Vaccine Immunol; 2015 Dec; 22(12):1227-34. PubMed ID: 26424832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine.
    Beernink PT; Welsch JA; Harrison LH; Leipus A; Kaplan SL; Granoff DM
    J Infect Dis; 2007 May; 195(10):1472-9. PubMed ID: 17436227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cocrystal structure of meningococcal factor H binding protein variant 3 reveals a new crossprotective epitope recognized by human mAb 1E6.
    Bianchi F; Veggi D; Santini L; Buricchi F; Bartolini E; Lo Surdo P; Martinelli M; Finco O; Masignani V; Bottomley MJ; Maione D; Cozzi R
    FASEB J; 2019 Nov; 33(11):12099-12111. PubMed ID: 31442074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of factor H Binding Protein sub-variants among Neisseria meningitidis in China.
    Shi F; Zhang A; Zhu B; Gao Y; Xu L; Li Y; Yin Z; Li J; Xie N; Shao Z
    Vaccine; 2017 Apr; 35(18):2343-2350. PubMed ID: 28351732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Diversity of Meningococcal Serogroup B Vaccine Antigens among Carriage Isolates Collected from Students at Three Universities in the United States, 2015-2016.
    Marjuki H; Chang HY; Topaz N; Whaley MJ; Vuong J; Chen A; Jenkins LT; Hu F; Schmink S; Retchless AC; Thomas JD; Acosta AM; McNamara LA; Soeters HM; Mbaeyi S; Wang X
    mBio; 2021 May; 12(3):. PubMed ID: 34006659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis.
    Murphy E; Andrew L; Lee KL; Dilts DA; Nunez L; Fink PS; Ambrose K; Borrow R; Findlow J; Taha MK; Deghmane AE; Kriz P; Musilek M; Kalmusova J; Caugant DA; Alvestad T; Mayer LW; Sacchi CT; Wang X; Martin D; von Gottberg A; du Plessis M; Klugman KP; Anderson AS; Jansen KU; Zlotnick GW; Hoiseth SK
    J Infect Dis; 2009 Aug; 200(3):379-89. PubMed ID: 19534597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1.
    Marini A; Rossi O; Aruta MG; Micoli F; Rondini S; Guadagnuolo S; Delany I; Henderson IR; Cunningham AF; Saul A; MacLennan CA; Koeberling O
    PLoS One; 2017; 12(7):e0181508. PubMed ID: 28742866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of complement factor H to PorB3 and NspA enhances resistance of Neisseria meningitidis to anti-factor H binding protein bactericidal activity.
    Giuntini S; Pajon R; Ram S; Granoff DM
    Infect Immun; 2015 Apr; 83(4):1536-45. PubMed ID: 25644002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of factor H binding protein beyond serogroup B: variation among five serogroups of invasive Neisseria meningitidis in South Africa.
    Mothibeli KM; du Plessis M; von Gottberg A; Murphy E; Hoiseth SK; Zlotnick G; Klugman KP
    Vaccine; 2011 Mar; 29(11):2187-92. PubMed ID: 21144918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of Complement Factor H (FH) Decreases Protective Anti-FH Binding Protein Antibody Responses of Infant Rhesus Macaques Immunized With a Meningococcal Serogroup B Vaccine.
    Granoff DM; Costa I; Konar M; Giuntini S; Van Rompay KK; Beernink PT
    J Infect Dis; 2015 Sep; 212(5):784-92. PubMed ID: 25676468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease.
    Jiang HQ; Hoiseth SK; Harris SL; McNeil LK; Zhu D; Tan C; Scott AA; Alexander K; Mason K; Miller L; DaSilva I; Mack M; Zhao XJ; Pride MW; Andrew L; Murphy E; Hagen M; French R; Arora A; Jones TR; Jansen KU; Zlotnick GW; Anderson AS
    Vaccine; 2010 Aug; 28(37):6086-93. PubMed ID: 20619376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of genes encoding surface proteins used as vaccine antigens in meningococcal endemic and epidemic strain panels from Norway.
    Holst J; Comanducci M; Bambini S; Muzzi A; Comandi S; Oksnes J; DeTora L; Pizza M; Rappuoli R; Caugant DA
    Vaccine; 2014 May; 32(23):2722-31. PubMed ID: 24631075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus.
    Bambini S; Muzzi A; Olcen P; Rappuoli R; Pizza M; Comanducci M
    Vaccine; 2009 May; 27(21):2794-803. PubMed ID: 19428890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene variability and degree of expression of vaccine candidate factor H binding protein in clinical isolates of Neisseria meningitidis.
    Kelly A; Jacobsson S; Hussain S; Olcén P; Mölling P
    APMIS; 2013 Jan; 121(1):56-63. PubMed ID: 23030708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined.
    Biagini M; Spinsanti M; De Angelis G; Tomei S; Ferlenghi I; Scarselli M; Rigat F; Messuti N; Biolchi A; Muzzi A; Anderloni G; Brunelli B; Cartocci E; Buricchi F; Tani C; Stella M; Moschioni M; Del Tordello E; Colaprico A; Savino S; Giuliani MM; Delany I; Pizza M; Costantino P; Norais N; Rappuoli R; Masignani V
    Proc Natl Acad Sci U S A; 2016 Mar; 113(10):2714-9. PubMed ID: 26888286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evidence for the potential of a bivalent fHBP vaccine to prevent Neisseria meningitidis Serogroup C Disease.
    Harris SL; Zhu D; Murphy E; McNeil LK; Wang X; Mayer LW; Harrison LH; Jansen KU; Anderson AS
    Hum Vaccin; 2011; 7 Suppl(Suppl):68-74. PubMed ID: 21245657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties.
    Faleri A; Santini L; Brier S; Pansegrau W; Lo Surdo P; Scarselli M; Buricchi F; Volpini G; Genovese A; van der Veen S; Lea S; Tang CM; Savino S; Pizza M; Finco O; Norais N; Masignani V
    FASEB J; 2014 Apr; 28(4):1644-53. PubMed ID: 24371123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broad vaccine protection against Neisseria meningitidis using factor H binding protein.
    Findlow J; Bayliss CD; Beernink PT; Borrow R; Liberator P; Balmer P
    Vaccine; 2020 Nov; 38(49):7716-7727. PubMed ID: 32878710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of invasive serogroup B Neisseria meningitidis isolates from Spain during 2015-2018: Evolution of the vaccine antigen factor H binding protein (FHbp).
    Abad R; García-Amil C; Navarro C; Martín E; Martín-Díaz A; Vázquez JA
    J Infect; 2021 Apr; 82(4):37-44. PubMed ID: 33610688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.